Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-20 4:58 pm Sale | 2025-08-19 | 13D | Marker Therapeutics, Inc. MRKR | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 641,801 4.960% | -18,100 (-2.74%) | Filing History |
| 2025-08-19 2:42 pm Sale | 2025-08-15 | 13D | Marker Therapeutics, Inc. MRKR | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 659,901 5.100% | -166,284 (-20.13%) | Filing History |
| 2024-01-09 12:32 pm Sale | 2020-12-16 | 13G | AlloVir, Inc. ALVR | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 232,864 4.690% | -9,003 (-3.72%) | Filing History |
| 2024-01-09 12:29 pm Purchase | 2020-07-29 | 13G | AlloVir, Inc. ALVR | John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 | 241,868 8.980% | 241,868 (New Position) | Filing History |